Koyfin Home > Directory > Health Care > Accelerate Diagnosti > EBITDA / Interest Expenses

Accelerate Diagnosti EBITDA / Interest Expenses Chart (AXDX)

Accelerate Diagnosti annual/quarterly EBITDA / Interest Expenses from 2012 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Accelerate Diagnosti EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $-4m a -21.54% increase of 1m year over year
  • Accelerate Diagnosti EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-4m a -14.49% increase of 1m year over year
  • Accelerate Diagnosti Annual EBITDA / Interest Expenses for 2019 was $-5m a -59.55% increase of 3m from 2018
  • Accelerate Diagnosti Annual EBITDA / Interest Expenses for 2018 was $-8m a -142,081.58% increase of 10,932m from 2017
  • Accelerate Diagnosti Annual EBITDA / Interest Expenses for 2015 was $-10,939m a 60.69% decrease of -6,639m from 2014
Other Ratios Metrics:
  • Accelerate Diagnosti Total Debt / Capital for the quarter ending September 09, 2018 was $60m a 99.98% increase of 60m year over year
  • Accelerate Diagnosti Other Liabilities for the quarter ending December 12, 2018 was $0m a 52.83% increase of 0m year over year
  • Accelerate Diagnosti Total Debt / Equity for the quarter ending September 09, 2018 was $152m a 99.99% increase of 152m year over year
View Chart On Koyfin

Quarterly AXDX EBITDA / Interest Expenses Data

06/2020$-4m
03/2020$-4m
12/2019$-5m
09/2019$-5m
06/2019$-5m
03/2019$-5m
12/2018$-6m
09/2018$-6m
06/2018$-6m
03/2018$-128m

Annual AXDX EBITDA / Interest Expenses Data

2019$-5m
2018$-8m
2015$-10,939m
2014$-4,300m